Insiders · Profile

Heineman Thomas Charles

Chief Medical Officer at ONCOLYTICS BIOTECH. Filing since 12 Feb 2026. CIK 0002103579

Company

Date

Role

Action

Amount

Of holding

12 Feb 2026

Chief Medical Officer

Bought

12,132

$10.03K

4.5%

1 decision on file.